Due to the high surface area to mass ratio of the particulates, the powdered drug is highly cohesive. Therefore, a larger carrier, such as lactose, is applied to de-agglomerate the drug particles and optimize the deposition of the drug in the lung.
We have launched DIPLACTM an Innovative solution as Inhalational grade Lactose for the fastest growing and most significant form of inhaled treatments; Dry Powder Inhalers (DPI).
The properties of the inhalation lactose are chosen based on the different parameters, like the device, filling platform, type of drug and how it is processed and the required drug release.
We at IIEPL provide a broad range of inhalation lactose grades – DIPLACTM, enabling tailored selection and blending to meet specific device and formulation requirements.